Tci Wealth Advisors, Inc. Beam Therapeutics Inc. Transaction History

Tci Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$39.79 - $70.31 $596 - $1,054	-15 Reduced 7.08%	197 $9,000
Q2 2022 Jul 19, 2022	BUY	$29.86 - $62.36 $4,060 - $8,480	136 Added 178.95%	212 $8,000
Q1 2022 Apr 29, 2022	BUY	$53.73 - $82.16 $3,277 - $5,011	61 Added 406.67%	76 $4,000
Q4 2021 Jan 24, 2022	SELL	$68.02 - $99.06 $8,842 - $12,877	-130 Reduced 89.66%	15 $1,000
Q3 2021 Oct 29, 2021	BUY	$84.37 - $133.6 $1,181 - $1,870	14 Added 10.69%	145 $13,000
Q2 2021 Aug 02, 2021	BUY	$64.12 - $128.71 $3,590 - $7,207	56 Added 74.67%	131 $17,000
Q1 2021 Apr 29, 2021	BUY	$71.28 - $120.75 $4,276 - $7,245	60 Added 400.0%	75 $6,000
Q3 2020 Oct 20, 2020	BUY	$19.0 - $30.57 $285 - $458	15 New	15 $0

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.